# 蝶针套装市场

> 蝶针套件市场研究报告按针规（19G、21G、23G、25G、27G）、按材料（不锈钢、聚丙烯、聚乙烯）、按安全机制（可回收针、不可回收针）、按应用（采血、静脉治疗、皮下注射）、按最终用户（医院和诊所、居家医疗、兽医诊所）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.77%
- **2024:** $ 0.85 Billion
- **2025:** $ 0.88 Billion
- **2035:** $ 1.28 Billion
- **Key Players:** Becton Dickinson and Company (US), Terumo Corporation (JP), Smiths Medical (US), Nipro Corporation (JP), Medtronic plc (IE), Fresenius Kabi AG (DE), Vygon S.A. (FR), Halyard Health, Inc. (US), B. Braun Melsungen AG (DE)

**Report ID:** MRFR/HC/27417-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/butterfly-needle-set-market-29124

---

## Market Summary

## **Butterfly Needle Set Market Overview**

As per MRFR analysis, the Butterfly Needle Set Market Size was estimated at 0.85 (USD Billion) in 2024. The Butterfly Needle Set Market Industry is expected to grow from 0.88 (USD Billion) in 2025 to 1.23 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.77% during the forecast period (2025 - 2034).

**Key Butterfly Needle Set Market Trends Highlighted**

Butterfly needle sets, designed for intravenous and subcutaneous injections, are gaining prominence in healthcare settings. Driven by the increasing prevalence of chronic diseases and the growing need for minimally invasive procedures, the butterfly needle set market is poised for significant growth in the coming years.

The rising demand for precision in drug delivery and patient comfort is fueling the adoption of butterfly needle sets, which offer accurate injections and reduce discomfort compared to traditional needles.

Technological advancements, such as the development of safety features like needle shields and ergonomic designs, are also driving market growth. Moreover, the growing use of butterfly needle sets in home and ambulatory care settings provides significant opportunities for market expansion.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Butterfly Needle Set Market Drivers**

Increasing Prevalence of Chronic Diseases

Chronic diseases such as diabetes, cancer, and kidney disease are on the rise globally. These conditions often require frequent blood draws and injections, which has led to an increased demand for butterfly needle sets.

Butterfly needles are less painful and easier to use than traditional needles, making them an ideal choice for patients who require frequent blood draws or injections. The increasing prevalence of chronic diseases is a major factor driving the growth of the butterfly needle set market.

Growing Demand for Minimally Invasive Procedures

Minimally invasive procedures are becoming increasingly popular as they offer a number of advantages over traditional open surgery. These procedures require the use of smaller needles and incisions, which has created a demand for butterfly needle sets.

Butterfly needles are ideal for minimally invasive procedures because they are less traumatic and reduce the risk of complications. The growing demand for minimally invasive procedures is another major factor driving the growth of the butterfly needle set market.

Technological Advancements

Technological advancements are also contributing to the growth of the butterfly needle set market. The development of new needle designs and materials has made butterfly needles more effective and easier to use.

For example, some butterfly needles are now coated with a special lubricant that reduces pain during insertion. Other butterfly needles are designed with a safety feature that prevents accidental needle sticks. These technological advancements are making butterfly needle sets more attractive to patients and healthcare professionals.

**Butterfly Needle Set Market Segment Insights:**

**Butterfly Needle Set Market Needle Gauge Insights**

The Needle Gauge segment of the Butterfly Needle Set Market is categorized into 19G, 21G, 23G, 25G, and 27G. Among these, the 23G segment is projected to dominate the market, accounting for a revenue share of around 35% in 2024.

This dominance can be attributed to the widespread use of 23G needles in various clinical applications, including blood collection, injections, and IV therapy. Furthermore, the growing demand for minimally invasive procedures is expected to fuel the demand for 23G butterfly needles. The 25G segment is anticipated to witness a steady growth rate over the forecast period.

The increasing prevalence of chronic diseases, such as diabetes and anemia, is driving the demand for frequent blood draws. As 25G needles are commonly used for these procedures, the segment is expected to benefit from this trend.

The 19G and 21G segments are also projected to experience significant growth, owing to their suitability for larger blood draws and injections. These needles are often used in emergency situations, blood transfusions, and the administration of medications that require higher flow rates. The 27G segment is expected to account for a smaller share of the market compared to the other segments.

This can be attributed to its limited use in specific applications, such as pediatric care and fragile veins. However, the segment is expected to witness a stable growth rate due to its advantages in minimizing pain and discomfort during injections.

Overall, the Needle Gauge segment of the Butterfly Needle Set Market is expected to exhibit steady growth over the coming years, driven by the increasing demand for minimally invasive procedures, the rising prevalence of chronic diseases, and the growing adoption of advanced healthcare technologies.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Butterfly Needle Set Market Material Insights**

The Butterfly Needle Set Market is segmented by Material into Stainless Steel, Polypropylene, and Polyethylene. The Stainless-Steel segment holds the largest market share due to its durability, corrosion resistance, and ability to withstand repeated sterilization.

The Polypropylene segment is expected to grow at a significant rate due to its low cost, lightweight, and flexibility. The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and growing awareness about the benefits of butterfly needle sets.

**Butterfly Needle Set Market Safety Mechanism Insights**

The Safety Mechanism segment plays a crucial role in the Butterfly Needle Set Market, offering distinct features and benefits to healthcare professionals. Retractable Needle and Non-Retractable Needle are the two primary types of Safety Mechanisms available in the market.

Retractable Needle sets feature a protective sheath that automatically covers the needle after use, reducing the risk of needlestick injuries for healthcare workers. Non-Retractable Needle sets, on the other hand, do not have a retractable mechanism, making them more cost-effective but posing a higher risk of accidental needle sticks.

In 2023, the Retractable Needle segment held the dominant share in the Butterfly Needle Set Market revenue, accounting for approximately 60%. The growing emphasis on safety in healthcare settings and government regulations mandating the use of safety-engineered medical devices have contributed to this dominance.

The Non-Retractable Needle segment is projected to witness a steady growth rate, primarily driven by its lower cost compared to Retractable Needles. The Butterfly Needle Set Market segmentation provides valuable insights into the market dynamics, enabling manufacturers to tailor their product offerings and strategies accordingly.

This data empowers stakeholders to make informed decisions and capitalize on growth opportunities within the industry.

**Butterfly Needle Set Market Application Insights**

The Application segment of the Butterfly Needle Set Market holds significant importance, influencing market growth and dynamics. Blood Collection, Intravenous Therapy, and Subcutaneous Injections are the key applications driving the market's expansion.

Blood Collection accounted for the largest revenue share in the Butterfly Needle Set Market in 2023, owing to its widespread use in medical facilities and laboratories for collecting blood samples for diagnostic purposes. The increasing prevalence of chronic diseases and the growing demand for regular blood monitoring contribute to the segment's growth.

Intravenous Therapy is another major application, accounting for a substantial market share. Butterfly needle sets are commonly used in hospitals, clinics, and home healthcare settings for administering intravenous fluids, medications, and nutrients directly into the bloodstream.

The rising incidence of infectious diseases and the increasing number of patients requiring intravenous treatment drive the segment's expansion. Subcutaneous Injections, used to deliver medications or fluids beneath the skin, also contribute to the Butterfly Needle Set Market growth.

This application is gaining traction due to the growing prevalence of diabetes, autoimmune disorders, and other conditions requiring self-administered injections.

Overall, the Application segment offers valuable insights into the specific end-uses of Butterfly Needle Sets, highlighting the key factors influencing demand and growth opportunities within the Butterfly Needle Set Market.

**Butterfly Needle Set Market End User Insights**

The Butterfly Needle Set Market is segmented by end user into hospitals and clinics, home healthcare, and veterinary clinics. Hospitals and clinics were the largest end user segment, accounting for over 60% of the global market revenue in 2023. The growth of this segment is attributed to the increasing number of surgeries and invasive procedures performed in hospitals and clinics.

Home healthcare is likely to be the fastest-growing end user segment, with a projected CAGR of over 4% from 2024 to 2032. This growth is driven by the rising demand for home healthcare services, such as infusion therapy and blood transfusions, due to the increasing prevalence of chronic diseases and the growing elderly population.

Veterinary clinics are a relatively small end user segment, but they are expected to experience steady growth over the forecast period due to the increasing number of companion animals and the rising demand for veterinary care.

**Butterfly Needle Set Market Regional Insights**

The Butterfly Needle Set Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest share of the market in 2023 and is expected to continue to dominate the market throughout the forecast period.

The growth of the North American market is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and favorable reimbursement policies. Europe is the second largest market for butterfly needle sets, with a significant presence of major manufacturers and a well-established healthcare system.

The APAC region is expected to witness the fastest growth over the forecast period, due to the increasing healthcare expenditure, rising population, and growing awareness of minimally invasive procedures. South America and MEA are expected to have a relatively smaller market share but are expected to grow steadily over the forecast period.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Butterfly Needle Set Market Key Players and Competitive Insights:**

Major players in the Butterfly Needle Set Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolio, and acquiring smaller players.

Leading Butterfly Needle Set Market players are focusing on developing innovative products that cater to the specific needs of end-users, such as those with diabetes or other chronic conditions that require frequent injections.

The Butterfly Needle Set Market development is also being driven by the increasing adoption of home healthcare services, which is leading to a growing demand for disposable and easy-to-use medical devices.

The competitive Landscape of Butterfly Needle Set Market is expected to remain highly competitive in the coming years, with major players continuing to invest in new technologies and products to maintain their market share.

Becton, Dickinson and Company is a leading medical technology company that manufactures and markets a wide range of medical devices, including Butterfly Needle Set. The company has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation.

Becton, Dickinson and Company is known for its high-quality products and its commitment to innovation. The company is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years.

Terumo Medical Corporation is another major player in the Butterfly Needle Set Market. The company manufactures and markets a wide range of medical devices, including blood transfusion sets, IV therapy sets, and Butterfly Needle Set.

Terumo Medical Corporation has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation. The company is known for its high-quality products and its commitment to customer service.

Terumo Medical Corporation is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years.

**Key Companies in the Butterfly Needle Set Market Include:**

**Butterfly Needle Set Market Developments**

_The increasing prevalence of chronic diseases, such as diabetes, and the growing adoption of minimally invasive procedures are key factors driving market growth._

_The rising geriatric population and the increasing demand for home healthcare services are also contributing to the market expansion. Furthermore, technological advancements, such as the development of atraumatic needles and safety features, are expected to propel market growth in the coming years._

_Key players in the market include Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, and Nipro Corporation. In 2023, the market was valued at USD 0.79 billion._

**Butterfly Needle Set Market Segmentation Insights**

**Butterfly Needle Set Market Needle Gauge Outlook**

**Butterfly Needle Set Market Material Outlook**

**Butterfly Needle Set Market Safety Mechanism Outlook**

**Butterfly Needle Set Market Application Outlook**

**Butterfly Needle Set Market End User Outlook**

**Butterfly Needle Set Market Regional Outlook**

## Market Drivers

### 老年人口增加

蝶针套件市场因老年人口的增加而有望增长，这部分人群更容易出现需要频繁医疗干预的健康问题。预计到2050年，全球65岁及以上人口将翻一番，因此对便于静脉穿刺的医疗设备的需求可能会增加。蝶针对老年患者尤其有利，因为它们可以减少不适感并降低并发症的风险。这一人口结构的变化表明，随着医疗系统适应老龄化人群的需求，蝶针套件的需求将持续存在。

### 日益关注微创手术

蝶针套件市场受益于各个医疗领域对微创手术日益重视。这些手术因其缩短的恢复时间和较低的并发症风险而受到青睐。蝶针凭借其精确进入静脉的设计，越来越多地应用于门诊和儿科患者。微创设备市场预计将扩展，预计未来几年复合年增长率将超过10%。这一趋势表明，蝶针套件将在医疗实践的演变中发挥关键作用。

### 医疗设备中的技术创新

蝶针套件市场受到持续技术创新的影响，这些创新增强了医疗设备的功能性和安全性。最近的进展包括开发安全工程蝶针，减少了针刺伤的风险。这些创新至关重要，因为针刺伤对医疗工作者构成了重大健康风险。预计安全工程设备的市场将增长，估计到2026年市场规模将超过50亿美元。这一增长表明向更安全的医疗实践转变，进一步推动了对蝶针套件的需求。

### 慢性疾病的发病率上升

蝶针套件市场正在增长，原因是慢性疾病（如糖尿病和心血管疾病）的发病率不断上升。由于这些疾病需要频繁的血液采样和静脉通道，蝶针的需求预计将会上升，因为它们以使用方便和患者舒适著称。根据最新数据，糖尿病的发病率预计到2045年将达到7亿例，这可能会显著推动对蝶针套件的需求。这一趋势表明，医疗设备的需求将持续存在，因为医疗服务提供者寻求有效的解决方案来管理慢性疾病。

### 增强医疗专业人员的培训和教育

蝶针套件市场也受到医疗专业人员培训和教育项目增强的推动。随着医疗环境的演变，越来越强调静脉穿刺的正确技术和蝶针的使用。培训计划旨在改善患者的治疗结果，并减少与抽血相关的并发症。随着越来越多的医疗机构采用全面的培训项目，使用蝶针套件的熟练程度可能会提高。这种对教育的关注可能会导致这些设备在临床环境中的更高采用率。

## Future Outlook

蝶针套件市场预计将在2024年至2035年间以3.77%的年均增长率增长，推动因素包括对微创手术需求的增加和医疗技术的进步。

**New opportunities:**

- 进入新兴市场，提供量身定制的产品。

到2035年，蝶针套件市场预计将实现强劲增长，反映出不断变化的医疗需求。

## Segment Insights

### 按针头规格：21G（最大）与23G（增长最快）

在蝶针套件市场中，针规的市场份额分布显示，21G针规主导了该细分市场，适用于从儿科到一般用途的广泛应用。对21G针的偏好增加归因于其多功能性以及在舒适性和性能之间的平衡，使其成为医疗服务提供者的首选。同时，23G针规显示出良好的增长势头，受到对微创手术需求增加和提升患者舒适度趋势的推动。23G针规细分市场的增长主要受到技术进步的刺激，这些进步增强了针头设计并改善了用户体验。随着医疗行业越来越重视以患者为中心的策略和微创治疗选项，23G针规已成为寻求减少患者创伤的临床医生的有利选择。医疗实践的持续演变以及用户的积极反馈表明，23G针规细分市场在未来几年将呈现强劲的上升轨迹。

21G（主导）与25G（新兴）

21G针规在蝶形针套件市场中仍然占据主导地位，以其在各种临床环境中的广泛适用性和有效性而受到赞誉。由于其在血流的足够腔径和对患者的最小不适之间取得了良好的平衡，因此其采用率显著较高。该针规不仅广泛用于常规静脉穿刺，还用于需要可靠性的特殊场景。相反，25G针规作为一个新兴细分市场逐渐崭露头角，特别适用于需要更细针和减少组织创伤的程序。对医疗实践中更少侵入性技术的日益重视支持了25G针规的崛起，使其在儿科护理和需要增强患者舒适度的情况下越来越受到青睐。这种主导与新兴针规之间的动态关系反映了不断演变的临床偏好。

### 按材料：不锈钢（最大）与聚丙烯（增长最快）

在蝶针市场中，材料组成在产品性能和消费者偏好中起着决定性作用。不锈钢目前主导市场，因其耐用性、生物相容性和易于消毒的特点。它构成了蝶针生产的支柱，因其优越的机械性能，使其成为全球医疗机构和专业人士的首选。另一方面，聚丙烯因其轻便特性和成本效益而逐渐受到青睐，吸引了市场上注重预算的买家。
这一细分市场的增长趋势显示出对多功能和高性能材料的需求日益增加。对感染控制的日益关注和医疗技术的进步促使了对不锈钢的偏好。同时，塑料的持续创新和可生物降解聚丙烯变体的发展正在推动聚丙烯细分市场的增长，表明消费者基础正在转变，越来越重视可持续性和功能性。

材料：不锈钢（主导）与聚丙烯（新兴）

不锈钢以其强度、耐腐蚀性和能够承受反复消毒过程的能力而著称，这使其成为蝶针套件市场的主导材料。它因提供可靠的性能和确保患者安全而广受认可，因此在关键应用中受到青睐。相反，聚丙烯因其轻便和灵活的特性而逐渐成为一种可行的替代品。它显著降低了生产成本，吸引了希望制造经济型医疗设备的制造商。这一向聚丙烯的转变得到了其配方创新的支持，以增强其机械性能并改善患者在使用蝶针时的体验。

### 通过安全机制：可伸缩针（最大）与不可伸缩针（增长最快）

在蝶针套件市场中，安全机制的细分主要由可回收针头主导，由于其增强的安全特性，最大限度地减少了针刺伤害，因此占据了最大的市场份额。这些针头因其易于使用和有效的回收机制而受到医疗服务提供者的青睐，有助于提高患者和工作人员的整体安全性。相反，不可回收针头作为一种新兴替代品正在受到关注，特别是在寻求具有成本效益的解决方案的市场中，同时确保基本的安全措施。

安全机制：可伸缩针（主流）与不可伸缩针（新兴）

可收回针头被视为蝶形针套件市场的主导安全机制，因其创新设计使得在使用后能够安全收回针头。这一特性显著降低了意外针刺伤害的风险，而这在医疗环境中是一个主要关注点。相比之下，虽然非可收回针头在历史上更为传统，但它们在市场上作为一种竞争选项正在崭露头角。它们吸引那些寻求更具预算友好型替代方案的医疗服务提供者，同时仍保持基本的安全性。然而，与可收回变体相比，它们缺乏先进的安全特性，这可能限制了它们的吸引力。

### 按应用：血液采集（最大）与静脉治疗（增长最快）

在蝶针套件市场中，应用细分展示了多样化的用途，其中血液采集因在实验室和临床环境中的广泛需求而成为最大的细分市场。血液采集对于诊断测试和健康状况监测至关重要，使其成为医疗服务提供者的首选。紧随其后，静脉治疗已成为增长最快的细分市场，受到慢性疾病日益普遍和高效药物输送系统需求增加的推动。

血液采集（主导）与静脉治疗（新兴）

血液采集仍然是蝴蝶针套市场的主导应用，主要由于其在诊断和患者监测中的重要性。该细分市场受益于成熟的实践和对可靠血样采集方法的强劲需求。静脉治疗被归类为新兴应用，正在迅速获得市场份额，这得益于医疗技术的进步和需要静脉治疗的疾病发生率的上升。随着医疗服务提供者优先考虑患者舒适度和程序效率，蝴蝶针套在静脉治疗中的采用持续增加，突显了医疗领域的有希望的转变。

### 按最终用户：医院和诊所（最大）与家庭医疗保健（增长最快）

在蝶针套件市场中，按最终用户细分显示，医院和诊所占据了市场的相当大份额。该细分市场的特点是由于需要蝶针的程序频率高而导致的高需求，主要用于采血和静脉治疗。家庭医疗保健也是一个重要的细分市场，反映了在传统医疗环境之外个性化护理的日益增长趋势。这两个细分市场结合在一起，展示了蝶针套件在各种医疗环境中的多样化应用和重要性。

蝶针套件市场的增长趋势表明，家庭医疗保健正显著增长，成为增长最快的细分市场。这一转变是由于对家庭医疗治疗的日益偏好，以及需要定期进行血液检测和治疗的老龄化人口，无需频繁前往医院。尽管医院和诊所仍然是最大的细分市场，但它们正在不断适应针头技术和患者需求的进步，保持在医疗服务中的关键角色。

医院和诊所（主导）与家庭医疗（新兴）

在蝶针套件市场中，医院和诊所被视为主导者，因为它们拥有成熟的基础设施以及大量需要针刺干预的患者。它们的运营效率依赖于系统性地使用蝶针进行安全和高效的血液采集和药物管理。相反，家庭医疗保健领域代表了一个新兴市场，需求迅速增长。这一增长受到慢性疾病增加和患者对便利护理选择偏好的推动。两个领域都是至关重要的，但它们的特点不同，医院专注于急性护理，而家庭医疗保健则强调患者的舒适性和可及性，促进了对适合在医院外使用的创新针具技术的需求。

## Regional Market Share Analysis

### 北美：医疗创新领袖

北美是蝶针套的最大市场，占全球市场份额的约45%。该地区的增长受到医疗支出增加、慢性疾病上升和医疗技术进步的推动。FDA等机构的监管支持进一步促进了市场扩展，确保医疗设备的安全性和有效性。对微创手术的需求也在上升，推动了市场增长。
美国是该地区的领先国家，拥有Becton Dickinson and Company和Smiths Medical等主要企业的显著存在。竞争格局以创新和主要公司之间的战略合作为特征。加拿大也发挥着重要作用，医疗基础设施投资不断增加，对先进医疗设备的认识日益增强。总体而言，北美市场有望继续增长，受技术进步和强大医疗系统的推动。

### 欧洲：监管框架与增长

欧洲是蝶针套的第二大市场，占全球市场份额的约30%。该地区的增长受到老龄化人口、慢性疾病的增加以及对患者安全和舒适的强烈重视的推动。医疗器械法规（MDR）等监管框架确保医疗设备的高标准，促进创新和新产品的市场准入。对微创手术的需求也是该地区的重要驱动因素。
欧洲的主要国家包括德国、法国和英国，Fresenius Kabi AG和B. Braun Melsungen AG等主要企业在这里占据重要地位。竞争格局以产品创新和制造商之间的战略合作为特征。成熟的医疗系统和日益重视以患者为中心的护理进一步增强了市场机会。总体而言，预计欧洲市场将稳步增长，受到监管进步和医疗投资增加的支持。

### 亚太地区：新兴市场潜力

亚太地区在蝶针套市场中是一个新兴的强国，占全球市场份额的约20%。该地区的增长受到医疗投资增加、人口上升和慢性疾病日益普遍的推动。中国和印度等国正在经历快速城市化和医疗基础设施的改善，这些都是市场扩展的重要催化剂。此外，旨在改善医疗服务可及性的政府举措进一步支持市场增长。
中国和日本是该地区的领先国家，Terumo Corporation和Nipro Corporation等主要企业在这里有强大的存在。竞争格局正在演变，本地制造商与成熟的全球企业一起获得了市场份额。先进医疗技术的日益采用和对患者舒适度的关注正在塑造市场动态。总体而言，亚太市场有望实现显著增长，受人口变化和医疗进步的推动。

### 中东和非洲：未开发的市场机会

中东和非洲地区的蝶针套市场正在逐渐增长，占全球市场份额的约5%。增长主要受到医疗支出增加、对先进医疗技术的认识提高以及慢性疾病日益普遍的推动。旨在改善医疗基础设施和医疗设备可及性的政府举措也在促进市场扩展。该地区多样化的医疗需求为增长提供了独特的机会。
该地区的主要国家包括南非和阿联酋，主要企业和本地制造商的存在不断增加。竞争格局以国际公司和地区公司混合为特征，努力满足对医疗设备日益增长的需求。对改善医疗服务和患者结果的关注正在推动市场的创新和投资。总体而言，中东和非洲市场预计将稳步增长，受到持续的医疗改革和投资的支持。

## Competitive Benchmarking

蝶针套件市场的特点是动态的竞争格局，受到对微创手术需求增加和医疗技术进步的推动。主要参与者如贝克顿·迪金森公司（美国）、Terumo公司（日本）和美敦力公司（爱尔兰）在战略上定位以利用创新并扩大市场存在。贝克顿·迪金森公司（美国）专注于通过持续的研究和开发来增强产品供应，而Terumo公司（日本）则强调区域扩张和合作伙伴关系，以加强其分销网络。美敦力公司（爱尔兰）似乎专注于数字化转型举措，将先进技术整合到其产品线中，这共同塑造了一个日益依赖技术进步和战略合作的竞争环境。

在商业策略方面，公司正在本地化制造以降低成本并优化供应链，这在全球经济波动的背景下尤为相关。市场结构适度分散，几家主要参与者对各个细分市场施加影响。这种分散性使得小众参与者能够出现，但主要公司的集体实力确保了竞争依然强劲且以创新为驱动。

2025年8月，贝克顿·迪金森公司（美国）宣布推出一系列专为儿童患者设计的新型蝶针，这突显了他们对满足特定市场需求的承诺。这一战略举措不仅增强了他们的产品组合，还使他们在需要专业解决方案的细分市场中处于有利位置，可能增加他们在专注于儿童护理的医疗提供者中的市场份额。

2025年9月，Terumo公司（日本）与一家领先的远程医疗平台达成战略合作，以将远程监测能力整合到他们的蝶针系统中。这一合作表明了向数字健康解决方案的更广泛趋势，表明Terumo希望通过技术提升患者结果，从而在竞争市场中实现差异化。

2025年10月，美敦力公司（爱尔兰）推出了一种新的基于人工智能的分析工具，旨在优化临床环境中蝶针的使用。这一创新反映了在医疗保健中整合人工智能的日益趋势，这可能显著提高程序效率和患者安全。通过采用这样的先进技术，美敦力可能会在市场上设定新的标准，进一步巩固其竞争优势。

截至2025年10月，蝶针套件市场正在见证强调数字化、可持续性和人工智能整合的趋势。战略联盟日益塑造竞争格局，使公司能够汇聚资源和专业知识。展望未来，预计竞争差异化将从传统的基于价格的策略演变为关注创新、技术进步和供应链可靠性，从而促进一个更具韧性和前瞻性的市场环境。

## Recent News & Developments

_慢性疾病（如糖尿病）的日益普遍以及微创手术的日益采用是推动市场增长的关键因素。_

_老年人口的增加和对居家医疗服务的需求上升也在促进市场扩张。此外，技术进步（如无创针和安全特性的开发）预计将在未来几年推动市场增长。_

_市场的主要参与者包括贝克顿、迪金森公司、泰尔茂公司、史密斯医疗和尼普罗公司。2023年，市场估值为7.9亿美元。_

## Report Scope

| 2024年市场规模 | 0.8493（十亿美元） |
| --- | --- |
| 2025年市场规模 | 0.8813（十亿美元） |
| 2035年市场规模 | 1.276（十亿美元） |
| 年复合增长率（CAGR） | 3.77%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 对微创手术的需求增长推动了蝴蝶针套市场的创新。 |
| 主要市场动态 | 对微创手术的需求上升推动了蝴蝶针套市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 蝴蝶针套市场的当前市场估值是多少？**
A: 截至2024年，蝴蝶针套件市场的市场估值为8.493亿美元。

**Q: 到2035年，蝶针套件市场的预计市场规模是多少？**
A: 预计到2035年，市场将达到12.76亿美元。

**Q: 在预测期内，蝶针套件市场的预期CAGR是多少？**
A: 从2025年到2035年，蝶针套件市场的预期CAGR为3.77%。

**Q: 在蝶针套件市场中，哪些公司被视为关键参与者？**
A: 市场上的主要参与者包括贝克顿·迪金森公司、Terumo Corporation 和史密斯医疗等。

**Q: 蝶针套件的主要应用是什么？**
A: 主要应用包括血液采集、静脉治疗和皮下注射。

**Q: 市场按针规细分的表现如何？**
A: 在2024年，针规市场细分显示19G的价值为0.1693亿美元，21G的价值为0.254亿美元。

**Q: 蝶针套件中常用的材料有哪些？**
A: 常见材料包括不锈钢，2024年的市场价值为4.2465亿美元，以及聚丙烯。

**Q: 在蝶针套件中有哪些类型的安全机制？**
A: 市场细分为可伸缩和非可伸缩针头安全机制，分别为 0.4246 亿美元和 0.4247 亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/butterfly-needle-set-market-29124*